ETheRNA etherna.be


Public list: BIO 2016 (619) Pharma Startups (4733) Cancer Therapeutics (1136)

eTheRNA looks to help patients overcome certain cancers and infectious diseases by developing novel immunotherapies that target fundamental role of dendritic cells in the human immune system. eTheRNA's proprietary mRNA-based TriMix technology boosts dendritic cells leading to a more comprehensive, sustainable and safer enhancement of the patient's immune system than any other similar approach investigated until now. TriMix comprises three mRNA molecules that jointly have a triple boost effect: (...Show all

eTheRNA looks to help patients overcome certain cancers and infectious diseases by developing novel immunotherapies that target fundamental role of dendritic cells in the human immune system. eTheRNA's proprietary mRNA-based TriMix technology boosts ...Show all

Company (Alive / Active)

Phone:

Fax:

VUB Campus Jette
Laarbeeklaan 103 - Building E
Jette, 1090
Belgium

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ETheRNA $26.5M Mar 18, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ETheRNA Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)